Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Star Imaging and Path Lab Ltd (STARIMAGIN) Share Price & Fundamentals

Company Overview

Founded Year

1978

Listed Year

2025

Headquarter

New Delhi, India

MD/CEO

-

Website

http://www.starimaging.in

Company Facts

What we do

Star Imaging and Path Lab Limited operates a NABL-accredited diagnostic network offering pathology, radiology, cardiology, and neurology services across India.

Founded in

1,978

Market share

A key regional diagnostic provider with strong presence in Delhi, Uttar Pradesh, and Nasik, serving B2C, B2B, and B2G clients.

Problem solved

Provides essential diagnostic testing for early disease detection, monitoring, and improved patient outcomes using advanced medical technologies.

Top clients or who we serve

Serves individual patients, corporate clients, and government agencies across multiple Indian states (B2C, B2B, B2G).

Key management

-

Our journey and innovations

Evolved from a clinic in 1978 to a modern pathology and imaging network established in 2004 with expansions and a tele-radiology hub.

Where we operate

India - primarily Delhi, Uttar Pradesh, and Nasik regions.

Top products or what we offer

Comprehensive diagnostic imaging and clinical laboratory tests including MRI, CT, X-rays, biochemistry, hematology, histopathology, and tele-radiology services.

Top brands

Star Imaging and Path Lab - known for NABL-accredited diagnostic services and tele-radiology hub providing centralized, scalable testing.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Most revenue is recurring, derived from continuous diagnostic service contracts and patient testing.

Our industry position

Emerging leader in regional diagnostic services with growing market share and expanding service offerings.

Financial highlights

FY 2023-24 revenue ₹78.5 crore with net profit ₹11.1 crore showing significant growth from previous year.

Geographical revenue split

Revenue primarily from Delhi, Uttar Pradesh, and Nasik regions in India.

Order book

-

Whats driving growth

Increased healthcare demand, technological upgrades, service expansion, and tele-radiology capabilities.

Our future plans

Focus on expanding domestic diagnostic network, enhancing service portfolio, and scaling tele-radiology hub.

Our green promise

-

Our people and values

Committed to ethical practices, employee welfare, and zero tolerance towards workplace harassment.

Key challenges ahead

Navigating regulatory changes, healthcare competition, and technology integration challenges.

Interesting facts

Started as a small clinic in 1978; evolved into a public company in 2024 with a substantial IPO in 2025 raising ₹69.47 crore.

Risks and strategy

Mitigates operational and regulatory risks through strong internal controls and ongoing innovation in diagnostics.

Market Footprint

Top Clients

Top Clients

Serves individual patients, corporate clients, and government agencies across multiple Indian states (B2C, B2B, B2G).

Top Products

Top Products

Comprehensive diagnostic imaging and clinical laboratory tests including MRI, CT, X-rays, biochemistry, hematology, histopathology, and tele-radiology services.

Price Movement & Share Holding

Today's High/Low

70.272.5

52 Week High/Low

46152
Past Returns

1 week

4.11%

1 month

-2.99%

3 month

-13.79%

1 year

-43.39%

3 year

-45.05%

5 year

-45.05%

Share Holding

Promoters

71.92%

FII

0.06%

DII

6.58%

Retail

18.55%

Others

2.9%

Company Overview

Founded Year

1978

Listed Year

2025

Headquarter

New Delhi, India

MD/CEO

-

Website

http://www.starimaging.in

Price Movement & Share Holding

Today's High/Low

70.272.5

52 Week High/Low

46152

Past Returns

1 week

4.11%

1 month

-2.99%

3 month

-13.79%

1 year

-43.39%

3 year

-45.05%

5 year

-45.05%

Share Holding

Promoters

71.92%

FII

0.06%

DII

6.58%

Retail

18.55%

Others

2.9%

Company Facts

What we do

Star Imaging and Path Lab Limited operates a NABL-accredited diagnostic network offering pathology, radiology, cardiology, and neurology services across India.

Founded in

1978

Market share

A key regional diagnostic provider with strong presence in Delhi, Uttar Pradesh, and Nasik, serving B2C, B2B, and B2G clients.

Problem solved

Provides essential diagnostic testing for early disease detection, monitoring, and improved patient outcomes using advanced medical technologies.

Top clients or who we serve

Serves individual patients, corporate clients, and government agencies across multiple Indian states (B2C, B2B, B2G).

Our journey and innovations

Evolved from a clinic in 1978 to a modern pathology and imaging network established in 2004 with expansions and a tele-radiology hub.

Where we operate

India - primarily Delhi, Uttar Pradesh, and Nasik regions.

Top products or what we offer

Comprehensive diagnostic imaging and clinical laboratory tests including MRI, CT, X-rays, biochemistry, hematology, histopathology, and tele-radiology services.

Top brands

Star Imaging and Path Lab - known for NABL-accredited diagnostic services and tele-radiology hub providing centralized, scalable testing.

Recurring vs cyclical contribution

Most revenue is recurring, derived from continuous diagnostic service contracts and patient testing.

Our industry position

Emerging leader in regional diagnostic services with growing market share and expanding service offerings.

Financial highlights

FY 2023-24 revenue ₹78.5 crore with net profit ₹11.1 crore showing significant growth from previous year.

Geographical revenue split

Revenue primarily from Delhi, Uttar Pradesh, and Nasik regions in India.

Whats driving growth

Increased healthcare demand, technological upgrades, service expansion, and tele-radiology capabilities.

Our future plans

Focus on expanding domestic diagnostic network, enhancing service portfolio, and scaling tele-radiology hub.

Our people and values

Committed to ethical practices, employee welfare, and zero tolerance towards workplace harassment.

Key challenges ahead

Navigating regulatory changes, healthcare competition, and technology integration challenges.

Interesting facts

Started as a small clinic in 1978; evolved into a public company in 2024 with a substantial IPO in 2025 raising ₹69.47 crore.

Risks and strategy

Mitigates operational and regulatory risks through strong internal controls and ongoing innovation in diagnostics.

Market Footprint

Top Clients

Top Clients

Serves individual patients, corporate clients, and government agencies across multiple Indian states (B2C, B2B, B2G).

Top Products

Top Products

Comprehensive diagnostic imaging and clinical laboratory tests including MRI, CT, X-rays, biochemistry, hematology, histopathology, and tele-radiology services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions